Image-guided tumor resection using real-time near-infrared fluorescence in a syngeneic rat model of primary breast cancer

Tumor involvement of resection margins is found in a large proportion of patients who undergo breast-conserving surgery. Near-infrared (NIR) fluorescence imaging is an experimental technique to visualize cancer cells during surgery. To determine the accuracy of real-time NIR fluorescence imaging in obtaining tumor-free resection margins, a protease-activatable NIR fluorescence probe and an intraoperative camera system were used in the EMR86 orthotopic syngeneic breast cancer rat model. Influence of concentration, timing and number of tumor cells were tested in the MCR86 rat breast cancer cell line. These variables were significantly associated with NIR fluorescence probe activation. Dosing and tumor size were also significantly associated with fluorescence intensity in the EMR86 rat model, whereas time of imaging was not. Real-time NIR fluorescence guidance of tumor resection resulted in a complete resection of 17 out of 17 tumors with minimal excision of normal healthy tissue (mean minimum and a mean maximum tumor-free margin of 0.2 ± 0.2 mm and 1.3 ± 0.6 mm, respectively). Moreover, the technique enabled identification of remnant tumor tissue in the surgical cavity. Histological analysis revealed that the NIR fluorescence signal was highest at the invasive tumor border and in the stromal compartment of the tumor. In conclusion, NIR fluorescence detection of breast tumor margins was successful in a rat model. This study suggests that clinical introduction of intraoperative NIR fluorescence imaging has the potential to increase the number of complete tumor resections in breast cancer patients undergoing breast-conserving surgery.

[1]  V. Kataja,et al.  Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of Screening , 2008, Clinical Cancer Research.

[2]  Thomas Pongratz,et al.  ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. , 2007, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[3]  J. Joyce,et al.  Cysteine Cathepsins and the Cutting Edge of Cancer Invasion , 2007, Cell cycle.

[4]  R. Weissleder,et al.  Fluorescence molecular tomography resolves protease activity in vivo , 2002, Nature Medicine.

[5]  J. Foekens,et al.  Prognostic significance of cathepsins B and L in primary human breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M. Morrow,et al.  A clinical oncologic perspective on breast magnetic resonance imaging. , 2010, Magnetic resonance imaging clinics of North America.

[7]  Mitsuharu Miwa,et al.  Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer , 2005, Breast cancer.

[8]  Jan Grimm,et al.  A spatially and temporally restricted mouse model of soft tissue sarcoma , 2007, Nature Medicine.

[9]  G. Birdsong,et al.  The Effects of Additional Tumor Cavity Sampling at the Time of Breast-Conserving Surgery on Final Margin Status, Volume of Resection, and Pathologist Workload , 2009, Annals of Surgical Oncology.

[10]  Stephen J. Lomnes,et al.  Tissue-like phantoms for near-infrared fluorescence imaging system assessment and the training of surgeons. , 2006, Journal of biomedical optics.

[11]  Ralph Weissleder,et al.  Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical model. , 2009, Gynecologic oncology.

[12]  R. Maehr,et al.  Live Imaging of Cysteine-Cathepsin Activity Reveals Dynamics of Focal Inflammation, Angiogenesis, and Polyp Growth , 2008, PloS one.

[13]  R. Golouh,et al.  Stefins and lysosomal cathepsins B, L and D in human breast carcinoma , 1992, International journal of cancer.

[14]  Bonnie F. Sloane,et al.  Cysteine cathepsins: multifunctional enzymes in cancer , 2006, Nature Reviews Cancer.

[15]  D. Hanahan,et al.  Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. , 2006, Genes & development.

[16]  Takeaki Ishizawa,et al.  Real‐time identification of liver cancers by using indocyanine green fluorescent imaging , 2009, Cancer.

[17]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[18]  Jouke Dijkstra,et al.  Novel Intraoperative Near-Infrared Fluorescence Camera System for Optical Image-Guided Cancer Surgery , 2010, Molecular imaging.

[19]  C. Cornelisse,et al.  A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy. , 1991, British Journal of Cancer.

[20]  A. Meining,et al.  Highly sensitive detection of early‐stage pancreatic cancer by multimodal near‐infrared molecular imaging in living mice , 2008, International journal of cancer.

[21]  A. Blejec,et al.  The expression of lysosomal proteinases and their inhibitors in breast cancer: Possible relationship to prognosis of the disease , 2008, Pathology & Oncology Research.

[22]  Michael Hünerbein,et al.  ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer , 2010, Breast Cancer Research and Treatment.

[23]  C. Cornelisse,et al.  Surgically induced cytokinetic responses in experimental rat mammary tumor models , 1991, Cancer.

[24]  T. Bates,et al.  Importance of routine cavity sampling in breast conservation surgery , 2009, The British journal of surgery.

[25]  L. Ngo,et al.  The FLARE™ Intraoperative Near-Infrared Fluorescence Imaging System: A First-in-Human Clinical Trial in Breast Cancer Sentinel Lymph Node Mapping , 2009, Annals of Surgical Oncology.

[26]  Andrew V Biankin,et al.  Real Time Intraoperative Confocal Laser Microscopy-Guided Surgery , 2009, Annals of surgery.

[27]  Hans Lippert,et al.  The cathepsin family and their role in colorectal cancer. , 2008, Pathology, research and practice.

[28]  R. Weissleder,et al.  Optical Imaging of Spontaneous Breast Tumors Using Protease Sensing ‘Smart’ Optical Probes , 2005, Investigative radiology.

[29]  K. Mai,et al.  Resection margin status in lumpectomy specimens of infiltrating lobular carcinoma , 2000, Breast Cancer Research and Treatment.

[30]  Vasilis Ntziachristos,et al.  Early photon tomography allows fluorescence detection of lung carcinomas and disease progression in mice in vivo , 2008, Proceedings of the National Academy of Sciences.

[31]  Ralph Weissleder,et al.  Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection--study in mice. , 2007, Radiology.

[32]  Douglas G Altman,et al.  Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.

[33]  K. Horst,et al.  Association of Clinical and Pathologic Variables with Lumpectomy Surgical Margin Status after Preoperative Diagnosis or Excisional Biopsy of Invasive Breast Cancer , 2007, Annals of Surgical Oncology.

[34]  Ralph Weissleder,et al.  Cellular activation of the self-quenched fluorescent reporter probe in tumor microenvironment. , 2002, Neoplasia.

[35]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[36]  Clifford Hoyt,et al.  Visualization of Microscopy‐Based Spectral Imaging Data from Multi‐Label Tissue Sections , 2008, Current protocols in molecular biology.

[37]  K. McMasters,et al.  Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique. , 2004, American journal of surgery.

[38]  H. Höfler,et al.  Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[39]  Miriam Scadeng,et al.  Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.

[40]  D. Farkas,et al.  Preclinical evaluation of nuclear morphometry and tissue topology for breast carcinoma detection and margin assessment , 2011, Breast Cancer Research and Treatment.

[41]  R. Weissleder,et al.  Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. , 2002, Radiology.

[42]  John V Frangioni,et al.  New technologies for human cancer imaging. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Kéramidas,et al.  Intraoperative near‐infrared image‐guided surgery for peritoneal carcinomatosis in a preclinical experimental model , 2010, The British journal of surgery.

[45]  A. Möller,et al.  Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer , 2008, The Journal of pathology.

[46]  Vasilis Ntziachristos,et al.  Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.